Corporate debt securities
Below is the list of AbbVie Inc. bonds, sorted by yield to worst. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTW % | Price % | Coupon % | Maturity date | Outstanding amt | Face value | S&P rating | Fitch rating | Issuer |
|---|---|---|---|---|---|---|---|---|---|
 ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064 | 5.90% | 93.94% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323042AbbVie Inc. 5.65% 15-MAR-2066 | 5.89% | 96.25% | 5.650% | 2066-03-15 | 500 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054 | 5.83% | 94.07% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049 | 5.83% | 80.02% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323041AbbVie Inc. 5.55% 15-MAR-2056 | 5.82% | 96.30% | 5.550% | 2056-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048 | 5.81% | 88.32% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAW9AbbVie Inc. 4.45% 14-MAY-2046 | 5.81% | 84.08% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055 | 5.81% | 97.12% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| 4ABBAbbVie Inc. 4.7% 14-MAY-2045 | 5.77% | 87.78% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044 | 5.73% | 90.14% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044 | 5.70% | 96.20% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042 | 5.66% | 86.69% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042 | 5.64% | 89.28% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045 | 5.62% | 88.67% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039 | 5.42% | 87.02% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAV1AbbVie Inc. 4.3% 14-MAY-2036 | 5.16% | 93.37% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| US287YAR0AbbVie Inc. 4.5% 14-MAY-2035 | 5.14% | 95.51% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6323043AbbVie Inc. 4.75% 15-MAR-2036 | 5.13% | 96.93% | 4.750% | 2036-03-15 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035 | 5.09% | 100.72% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035 | 5.08% | 96.24% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034 | 4.98% | 100.43% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322510AbbVie Inc. 4.4% 15-MAR-2033 | 4.90% | 97.17% | 4.400% | 2033-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322511AbbVie Inc. 4.125% 15-MAR-2031 | 4.75% | 97.40% | 4.125% | 2031-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030 | 4.64% | 100.77% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029 | 4.63% | 95.57% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031 | 4.60% | 101.40% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029 | 4.56% | 100.58% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028 | 4.45% | 100.30% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV6322513AbbVie Inc. 3.775% 03-MAR-2028 | 4.44% | 98.95% | 3.775% | 2028-03-03 | 1.5 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027 | 4.42% | 100.23% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028 | 4.42% | 99.61% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
 XS190919331Allergan Funding SCS 2.625% 15-NOV-2028 | 4.20% | 96.53% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | NR | — | Allergan Funding SCS |
| ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026 | 4.12% | 99.57% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | A− | — | AbbVie, Inc. |
| XS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 4.05% | 94.82% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | NR | — | Allergan Funding SCS |
| 4ABGAbbVie Inc. 1.25% 18-NOV-2031 | 3.27% | 90.21% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS212591483AbbVie Inc. 2.625% 15-NOV-2028 | 3.25% | 98.60% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS152090781AbbVie Inc. 2.125% 17-NOV-2028 | 2.99% | 98.05% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| XS212591491AbbVie Inc. 2.125% 01-JUN-2029 | 2.97% | 97.67% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| 4ABEAbbVie Inc. 0.75% 18-NOV-2027 | 2.91% | 97.16% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | A− | — | AbbVie, Inc. |
| ABBV6322512AbbVie Inc. FRN 03-MAR-2028 | — | 100.08% | 4.117% | 2028-03-03 | 750 M USD | 1,000.00 USD | A− | — | AbbVie, Inc. |